LDLR and atherosclerosis: Recently, our group showed that whole-body PHD1 deficiency in atherosclerosis-prone low-density lipoprotein receptor knockout (LDLR-ko) mice reduced atherosclerotic plaque size and necrotic plaque content as a result of protective effects on extrahepatic lipid metabolism and macrophage oxygen consumption (Marsch et al., 2016).